Our mission to bridge nature and health

We understand that whole-body health and wellness is tied to the complex ecosystem of microorganisms that is the microbiome, and that addressing healthy microbiome balance will transform people’s lives from the inside.
Our mission is simple: We want to empower people with products and nutritional information that help them live healthy, well-balanced lives. To that end, we aim to create products that have power and quality with the accessibility of a probiotic.

img

More than a microbiome scientist, our CEO is a mum.

Colleen Cutcliffe has an impressive background leading and managing biology teams. She’s a scientist with a Ph.D. in Biochemistry and Microbiology from Johns Hopkins University and has held senior positions at bioscience and pharmaceutical firms. She’s also a mum, not to mention our CEO.

Colleen and her two co-founders, John and Jim, saw an opportunity to apply next-generation DNA sequencing technologies and microbiological assays to the emerging microbiome science space. Using these data, they could create metabolic maps of the microbiome and use systems biology to make novel insights into the microbiome. This scientific trio was uniquely positioned to bring new products to the world.

It was her role as a mum, however, that inspired her to team up with her two former colleagues and create Pendulum. Colleen’s first daughter was born eight weeks prematurely. That meant instead of heading home that day with mum and dad, she was whisked away to the NICU for four weeks, receiving multiple doses of antibiotics as a precautionary measure due to her fragile state.

As she got older, Colleen began to notice distinct differences in Annabella’s metabolism compared to the rest of their family. She had to deal with food sensitivities in elementary school.
This led Colleen, John and Jim on their journey to find a solution to help support her daughter and many others who may need to support a healthy, balanced microbiome. And, this set the stage for the vision of the company to create a new generation of natural products that support the microbiome.

After nearly a decade of research, Pendulum was born and remains a central part of Colleen and Annabella’s wellness.

Colleen Cutcliffe

CEO AND CO-FOUNDER

Colleen Cutcliffe is the Chief Executive Officer and co-founder of Pendulum. She has more than 15 years of experience leading and managing biology teams in academia, pharmaceuticals, and biotechnology. Prior to starting Pendulum, Colleen was the senior manager of biology at Pacific Biosciences and a scientist at Elan Pharmaceuticals. Colleen completed her postdoctoral studies at Northwestern’s Children’s Memorial Hospital. Colleen received her Ph.D. in Biochemistry and Molecular Biology from John Hopkins University and her B.A. in Biochemistry from Wellesley College.

“I am excited to be at Pendulum working towards unlocking the promise of the microbiome and building products to improve the health and lives of millions of people. Leading a team of world-class experts in lab science, manufacturing, finance and commercialization who work together fantastically makes my job easy.”

Jim Bullard

CO-FOUNDER

Jim Bullard is Chief Technology Officer and co-founder of Pendulum. Prior, Jim served as a senior staff scientist at Pacific Biosciences. Prior to co-founding Pendulum, Jim completed his Ph.D. in Biostatistics at the University of California, Berkeley and his B.A. in Computing & Information Systems at Northwestern University. He has a passion for experimental design, programming languages, and taking long walks with his dog.

“I feel fortunate to be working with smart, motivated people on interesting problems. Building products that help people is incredibly motivating.”

John Eid

CSO AND CO-FOUNDER

John Eid is the Chief Science Officer and co-founder of Pendulum. John has led technology development teams for nearly two decades in diverse areas that include advanced microscopy, single molecular detection and analyses, automated data acquisition systems, biophysical systems modeling, and genome sequencing applications. Prior to co-founding Pendulum, John was a principal scientist at Pacific Biosciences. John completed his postdoctoral research at the Roland Institute at Harvard University, received his Ph.D. in Biophysics and Computational Biology at the University of Illinois, Urbana Champaign and his B.S. in Applied and Engineering Physics from Cornell University.

“It is exciting to have a front row seat on the evolution of the microbiome field from a purely academic endeavor into a field that is actually helping people in the here and now.”

Adam Perlman

CHIEF MEDICAL OFFICER

Dr. Perlman is board-certified in Internal Medicine and specializes in both integrative and functional medicine. With more than 25 years of clinical, entrepreneurial, and leadership experience, he most recently served as the Director of Integrative Health and Wellbeing at the Mayo Clinic. Prior to that, he served as the Associate Vice President for Health and Wellness for the Duke University Health System. Dr. Perlman received his BA from Tufts University, his MD from the Boston University School of Medicine, and his MPH from the Boston University School of Public Health.

"It is critical to educate people on how a targeted approach to a healthy gut microbiome can positively affect overall health and wellbeing to help them improve vitality and live their best lives."

We’re honored to serve alongside our prestigious board members.

Medical Advisory Board

ADAM D’AUGELLI

PARTNER

TRUE VENTURES

COLLEEN CUTCLIFFE

CEO

PENDULUM THERAPEUTICS

CRAIG SHERMAN, GENERAL PARTNER

MERITECH CAPITAL

HEATHER MASON

FMR. SVP

ABBOTT NUTRITION

FMR. SVP

ABBOTT DIAGNOSTICS

HUGH MARTIN

CEO

LACUNA TECHNOLOGIES SENSITY BIOSYSTEMS (ACQ VERIZON) PACIFIC BIOSCIENCES (IPO) ONI SYSTEMS (IPO)

JOHN EID

CSO

PENDULUM THERAPEUTICS

PETER BARTON HUTT, SENIOR COUNSEL

SENIOR COUNSEL

COVINGTON & BURLING

FMR. GENERAL COUNSEL

FDA

ROELOF BOTHA

SEED & EARLY, GROWTH PARTNER

SEQUOIA CAPITAL

Medical Advisory Board

ANNE PETERS, MD

DIRECTOR, CLINICAL DIABETES

UNIVERSITY OF SOUTHERN CALIFORNIA PRIVATE PRACTICE

CAROL WYSHAM, MD

PROFESSOR

UNIVERSITY OF WASHINGTON

PRACTITIONER

ROCKWOOD MULTICARE CENTER FOR DIABETES

DAVIDA KRUEGER, NP

NURSE PRACTITIONER

HENRY FORD HEALTH SYSTEM

CHAIR

AMERICAN DIABETES ASSOCIATION (ADA) RESEARCH FOUNDATION

EMERAN MAYER, MD

DIRECTOR, OPPENHEIMER CENTER FOR NEUROBIOLOGY OF STRESS AND RESILIENCE

PROFESSOR, DEPARTMENT OF MEDICINE

UCLA

JAY PASRICHA, MD

CHIEF OF MEDICINE

MAYO CLINIC

JOHN BUSE, MD

CHAIR, DIVISION OF ENDOCRINOLOGY

UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE

PURNA KASHYAP, MBBS

ASSOCIATE PROFESSOR, MEDICINE

MAYO CLINIC

ROBERT RATNER, MD

CHIEF MEDICAL OFFICER

VIRTA HEALTH

FMR CHIEF SCIENTIFIC & MEDICAL OFFICER

AMERICAN DIABETES ASSOCIATION

Scientific Advisory Board

ALFRED SPORMANN, PH.D.

PROFESSOR, CIVIL AND ENVIRONMENTAL ENGINEERING

STANFORD UNIVERSITY

CHRISTOPHER MASON, PH.D.

PROFESSOR

WEILL CORNELL MEDICINE

DIRECTOR OF EMERGING GENOME TECHNOLOGIES

TEMPUS LABS, INC.

DIETRICH STEPHAN, PH.D.

CEO

NEUBASE THERAPEUTICS

CHAIR, DEPARTMENT OF HUMAN GENETICS

UNIVERSITY OF PITTSBURGH

ERIC SCHADT, PH.D.

FOUNDER & CEO

SEMA4

DEAN FOR PRECISION MEDICINE

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

PETER TURNBAUGH, PH.D.

ASSISTANT PROFESSOR, DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY

UCSF

Investors

Early Supporters